Clozapine effective in olanzapine-induced Pisa syndrome

Annals of Pharmacotherapy

Volumn 40, Issue 12, 2006, Pages 2273-2275

  Arora, Manu ^a   Praharaj, Samir Kumar ^a   Sarkar, Sukanto ^a  

^a CENTRAL INSTITUTE OF PSYCHIATRY   (India)

Author keywords

Clozapine; Olanzapine; Pisa syndrome

Indexed keywords

CLOZAPINE; OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFICACY; DYSTONIA; HUMAN; HYPERSALIVATION; MALE; PARANOID SCHIZOPHRENIA; PISA SYNDROME; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; BENZODIAZEPINES; CLOZAPINE; DYSKINESIA, DRUG-INDUCED; DYSTONIA; HUMANS; MALE; SCHIZOPHRENIA, PARANOID; SYNDROME;

EID: 33845620378     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H325     Document Type: Article

References (21)

1. Ekbom K, Lindholm H, Ljungberg L. New dystonic syndrome associated with butyrophenone therapy. Z Neurol 1972;202:94-103.
2. Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982;32: 1335-46.
3. Yassa R. The Pisa syndrome: a report of two cases. Br J Psychiatry 1985;146:93-5.
4. Guy N, Raps A, Assael M. Dr. Guy and associates reply (letter). Am J Psychiatry 1987;144:970.
5. Stubner S, Padberg F, Grohmann R, et al. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry 2000;61:569-74.
6. Yassa R, Nastase C, Cvejic J, Laberge G. The Pisa syndrome (or pleurothotonus): prevalence in a psychogeriatric population. Biol Psychiatry 1991;29:942-5.
7. Suzuki T, Koizumi J, Moroji T, Sakuma K, Hori M, Hori T. Clinical characteristics of the Pisa syndrome. Acta Psychiatr Scand 1990;82:454-7.
8. Suzuki E, Kanba S, Nibuya M, et al. Use of pimozide in the Pisa syndrome (letter). Am J Psychiatry 1992;149:1114-5.
9. Kurtz G, Kapfhammer HP, Peuker B. [Pisa syndrome in clozapine therapy] (abstract). German. Nervenarzt 1993;64:742-6.
10. Ziegenbein M, Schomerus G, Kropp S. Ziprasidone-induced Pisa syndrome after clozapine treatment (letter). J Neuropsychiatry Clin Neurosci 2003;15:458-9.
11. Suzuki T, Kurita H, Hori T, et al. The Pisa syndrome (pleurothotonus) during antidepressant therapy. Biol Psychiatry 1997;41:234-6.
12. Cossu G, Melis M, Melis G, et al. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report. Mov Disord 2004;19:1243-4.
13. Yohanan M, Aulakh JS, Weith J, Hawkins JW. Pisa syndrome in a patient in a wheelchair taking valproic acid (letter). Am J Psychiatry 2006;163:325-6.
14. Guy W. ECDEU assessment manual for psychopharmacology. Washington, DC: US Department of Health, 1976:534-7.
15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
16. Suzuki T, Hori T, Baba A, et al. Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa syndrome) (letter). J Clin Psychopharmacol 1999;19:277-80.
17. Adityanjee, Aderibigbe YA, Jampala VC, Mathews T. The current status of tardive dystonia. Biol Psychiatry 1999;45:715-30.
18. Recimil MJ, Area R, Ozaita G, Lamas S. Reappearance of tardive dystonia with olanzapine treated with clozapine (letter). Schizophr Res 2005;76:357-8.
19. Trugman JM, Leadbetter R, Zalis ME, Burgdorf RO, Woolen GF. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Mov Disord 1994;9:441-6.
20. Slawek J, Derejko M, Lass P, Dubaniewicz M. Camptocormia or Pisa syndrome in multiple system atrophy. Clin Neurol Neurosurg 2006;108:699-704. Epub 19 Aug 2005.
21. Fichtner CG. Pleurothotonus and the Pisa syndrome (letter). Biol Psychiatry 1992;31:534.